ArticleProtein engineering, design & selection : PEDS2009

Engineering of a novel hybrid enzyme: an anti-inflammatory drug target with triple catalytic activities directly converting arachidonic acid into the inflammatory prostaglandin E2.

Ke-He Ruan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.